Success Stories: An Assistant Professor in the Field of Chemistry Receives EB-1A Approval with NAILG Representation in Only 19 Days, Also Thanks to the Premium Processing Service

Client’s Testimonial:

“I had an excellent experience working with Chen Immigration on my NIW case. They were professional, responsive, and always available to answer all the questions I had throughout the process. Their expertise and guidance made the entire experience smooth and stress-free. I’m grateful for their support and dedication in helping me achieve this important milestone. I truly appreciate your guidance throughout the process. Thank you.”

On March 26^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for an Assistant Professor in the Field of Chemistry (Approval Notice).

General Field: Chemistry

Position at the Time of Case Filing: Assistant Professor

Country of Origin: India

State of Residence at the Time of Filing: New Mexico

Approval Notice Date: March 26^th, 2025

Processing Time: 19 days (Premium Processing Requested)

Case Summary:

We are pleased to share the successful EB-1A (Alien of Extraordinary Ability) petition approval for a distinguished chemist whose groundbreaking work is transforming the fields of organometallic chemistry, environmental purification, and biomedical applications. Our client’s original research and sustained impact demonstrate his standing as one of the foremost experts in his field, with far-reaching implications for both public health and sustainable technology.

He has made original contributions of major significance to chemistry, including the development of organochalcogen compounds for use in biochemistry, material science, and pharmaceutical wastewater purification. His work has advanced environmentally sustainable air purification systems and contributed directly to improving indoor air quality, one of the most pressing environmental health challenges today. His innovations have also played a crucial role in reducing the cost and increasing the efficiency of air filtration technologies, with applications in both residential and industrial settings.

His career is marked by the following notable achievements:

26 peer-reviewed journal articles, including 7 as first or co-first author, 1 preprint, and 3 patents.
300 citations by researchers in at least 39 countries, reflecting the global relevance of his work.
At least 45 completed peer reviews, underscoring his role as a trusted evaluator in the scientific community.
Research funding from the Council of Scientific and Industrial Research (CSIR) in India, a respected national institution.

He is particularly well known for his synthesis, characterization, and biological exploration of organochalcogen compounds. His research in this area has not only broadened the scope of organometallic chemistry but has also created new pathways for bio-compatible applications and sustainable chemical processes.

His influence extends beyond the lab bench. As one expert testimonial noted:

“It is thus clear that [client]’s work has been critical to the commercial success of [client’s] company. Beyond financial gain, his innovations have advanced environmentally sustainable practices in air purification technology, reducing toxic emissions and promoting public health through cleaner air and safer manufacturing processes.”

Our client’s work exemplifies the type of high-impact, globally recognized research that the EB-1A category was designed to support. We are proud to have helped bring this petition to a successful outcome and look forward to his continued contributions to chemistry, clean technology, and public health innovation in the United States and beyond.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.